Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 32402160

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2020 May 14
First author
Finn RS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2020 May 14;382(20):1953-1955. doi: 10.1056/NEJMe2004851.
    note
    Source null
    related pmid
    32402168
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2020 Jul;17(7):389. doi: 10.1038/s41571-020-0396-9.
    note
    Source null
    related pmid
    32457541
    relationship
    Comment in
  3. citation
    N Engl J Med. 2020 Aug 13;383(7):693-694. doi: 10.1056/NEJMc2021840.
    note
    Source null
    related pmid
    32786198
    relationship
    Comment in
  4. citation
    N Engl J Med. 2020 Aug 13;383(7):694. doi: 10.1056/NEJMc2021840.
    note
    Source null
    related pmid
    32786199
    relationship
    Comment in
  5. citation
    N Engl J Med. 2020 Aug 13;383(7):694-695. doi: 10.1056/NEJMc2021840.
    note
    Source null
    related pmid
    32786200
    relationship
    Comment in
  6. citation
    Gastroenterology. 2021 Mar;160(4):1423-1424. doi: 10.1053/j.gastro.2020.12.013.
    note
    Source null
    related pmid
    33310087
    relationship
    Comment in
  7. citation
    Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):305-311. doi: 10.1016/j.ijrobp.2020.09.033.
    note
    Source null
    related pmid
    33422270
    relationship
    Comment in

Authors and identifiers

  1. name
    Finn RS
    type
    Author
  2. name
    Qin S
    type
    Author
  3. name
    Ikeda M
    type
    Author
  4. name
    Galle PR
    type
    Author
  5. name
    Ducreux M
    type
    Author
  6. name
    Kim TY
    type
    Author
  7. name
    Kudo M
    type
    Author
  8. name
    Breder V
    type
    Author
  9. name
    Merle P
    type
    Author
  10. name
    Kaseb AO
    type
    Author
  11. name
    Li D
    type
    Author
  12. name
    Verret W
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Finn RS
    type
    Author
  2. name
    Qin S
    type
    Author
  3. name
    Ikeda M
    type
    Author
  4. name
    Galle PR
    type
    Author
  5. name
    Ducreux M
    type
    Author
  6. name
    Kim TY
    type
    Author
  7. name
    Kudo M
    type
    Author
  8. name
    Breder V
    type
    Author
  9. name
    Merle P
    type
    Author
  10. name
    Kaseb AO
    type
    Author
  11. name
    Li D
    type
    Author
  12. name
    Verret W
    type
    Author
bibliography ids
  1. nci-bib-b7a5c8cec0ee2702e616a4ac
book metadata
content sha256
f9ec2bda2aa1c6f92e1a74466d159509afd3c60e65b2c755ba35dbdf2dd4d581
document type
citation
dois
  1. 10.1056/NEJMoa1915745
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32402160
immutable id
pubmed:32402160@f9ec2bda2aa1c6f92e1a74466d159509afd3c60e65b2c755ba35dbdf2dd4d581
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
20
name
The New England journal of medicine
nlm unique id
0255562
pages
1894-1905
volume
382
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2020 May 14;382(20):1953-1955. doi: 10.1056/NEJMe2004851.
    note
    Source null
    related pmid
    32402168
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2020 Jul;17(7):389. doi: 10.1038/s41571-020-0396-9.
    note
    Source null
    related pmid
    32457541
    relationship
    Comment in
  3. citation
    N Engl J Med. 2020 Aug 13;383(7):693-694. doi: 10.1056/NEJMc2021840.
    note
    Source null
    related pmid
    32786198
    relationship
    Comment in
  4. citation
    N Engl J Med. 2020 Aug 13;383(7):694. doi: 10.1056/NEJMc2021840.
    note
    Source null
    related pmid
    32786199
    relationship
    Comment in
  5. citation
    N Engl J Med. 2020 Aug 13;383(7):694-695. doi: 10.1056/NEJMc2021840.
    note
    Source null
    related pmid
    32786200
    relationship
    Comment in
  6. citation
    Gastroenterology. 2021 Mar;160(4):1423-1424. doi: 10.1053/j.gastro.2020.12.013.
    note
    Source null
    related pmid
    33310087
    relationship
    Comment in
  7. citation
    Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):305-311. doi: 10.1016/j.ijrobp.2020.09.033.
    note
    Source null
    related pmid
    33422270
    relationship
    Comment in
outcomes validated
false
pmid
32402160
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
c84cd602aef7012f558f7978efebc3fc0c7c356add1049c0f740e8ee67a83089
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 May 14
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32402160/
title
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Preserved source evidence · Independent clinical review pending · Not medical advice